Last reviewed · How we verify

NCT05085119: FiO2RI

Validation of the Relationship Between Oxygenation Parameters and ORI™, in Mechanically Ventilated ICU Patients

Completed NA Last updated 17 February 2023
What this trial tests

NA trial testing Stepwise modifications of FiO2 in Intubation in 30 participants. Completed in 10 August 2022.

Timeline
9 February 2021
Primary endpoint
10 August 2022
10 August 2022

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposeother
Enrollment30
Start date9 February 2021
Primary completion10 August 2022
Estimated completion10 August 2022
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Intubation or Mechanical Ventilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ORI™ or Oxygen Reserve Index (Masimo, Irvine, CA, USA) is a non-invasive monitoring system for measuring oxygen reserve. It is a digital sensor (almost identical to the SpO2 sensor) which allows an analysis of the absorption of arterial, venous and capillary components. The measured index, unitless, ranges from 0.00 to 1.00 for moderate hyperoxia levels: from 100 to 200 mmHg. It can alert the clinician to a drop in oxygen stores via the drop in SvO2 before a drop in SpO2 is observed. We propose to carry out a study to elucidate correlation between ORI™ and PaO2.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intubation

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05085119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing